Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett W Carter

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
European Radiology|December 17, 2025
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancerXiaoyu Han, Wentao Li, Julie Lin, et al.
Journal of the American College of Radiology : JACR|July 11, 2021
Managing Incidental Findings on Thoracic CT: Lung Findings. A White Paper of the ACR Incidental Findings CommitteeReginald F Munden, William C Black, Thomas E Hartman, et al.
JCO Precision Oncology|August 11, 2021
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic ProfilingHai T Tran, Vincent K Lam, Yasir Y Elamin, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Journal of the American College of Radiology : JACR|June 27, 2018
Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings CommitteeReginald F Munden, Brett W Carter, Caroline Chiles, et al.
Physics in Medicine and Biology|May 21, 2016
Characterizing proton-activated materials to develop PET-mediated proton range verification markersJongmin Cho, Geoffrey S Ibbott, Matthew D Kerr, et al.
Nature Medicine|April 25, 2018
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 29, 2019
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLCSteven H Lin, Yan Lin, Luyang Yao, et al.
Nature Medicine|August 20, 2024
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Thoracic Outlet Syndrome, Omar Zurkiya, Suvranu Ganguli, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
European Radiology|December 17, 2025
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancerXiaoyu Han, Wentao Li, Julie Lin, et al.
Journal of the American College of Radiology : JACR|July 11, 2021
Managing Incidental Findings on Thoracic CT: Lung Findings. A White Paper of the ACR Incidental Findings CommitteeReginald F Munden, William C Black, Thomas E Hartman, et al.
JCO Precision Oncology|August 11, 2021
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic ProfilingHai T Tran, Vincent K Lam, Yasir Y Elamin, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Journal of the American College of Radiology : JACR|June 27, 2018
Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings CommitteeReginald F Munden, Brett W Carter, Caroline Chiles, et al.
Physics in Medicine and Biology|May 21, 2016
Characterizing proton-activated materials to develop PET-mediated proton range verification markersJongmin Cho, Geoffrey S Ibbott, Matthew D Kerr, et al.
Nature Medicine|April 25, 2018
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 29, 2019
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLCSteven H Lin, Yan Lin, Luyang Yao, et al.
Nature Medicine|August 20, 2024
Author Correction: Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Thoracic Outlet Syndrome, Omar Zurkiya, Suvranu Ganguli, et al.
Pageof 18